Our study highlights a previously unrecognised role of non-canonical NF-κB activation in ETS1 regulation, whereby p52-induced ETS1 expression results in a multitude of genomic, transcriptional and functional events in glioma cancers. The gene discussed is NFKB1; the disease is central nervous system cancer.